Eubacterium hallii

Eubacterium hallii is a next-generation probiotic bacterium that produces short-chain fatty acids, particularly butyrate and propionate, which strengthen the intestinal barrier and reduce systemic inflammation. This beneficial microbe enhances energy metabolism by fermenting complex carbohydrates and supports immune function through the gut-immune axis.

Origin & History

Eubacterium hallii is a gram-positive, anaerobic bacterium found in the human gut microbiome. It is cultured in oxygen-free environments and is often isolated from fecal samples for study and potential therapeutic use.

Historical & Cultural Context

Eubacterium hallii was first identified as part of the human gut microbiota in the late 20th century. Its role in gut health has become a focus of recent scientific research.

Health Benefits

- Produces butyrate and propionate, which support gut health and reduce inflammation, essential for digestive comfort. - Enhances energy metabolism by breaking down complex carbohydrates, improving energy levels and endurance. - Boosts immune function by increasing the production of protective antibodies, reducing the risk of infections. - Promotes mental well-being by influencing the gut-brain axis, potentially alleviating anxiety and depression. - Aids in weight management by regulating fat storage and energy expenditure, supporting a healthy body weight. - Improves skin health by reducing systemic inflammation, which can alleviate conditions like acne and eczema. - Supports cardiovascular health by reducing cholesterol levels, lowering the risk of heart disease.

How It Works

Eubacterium hallii metabolizes complex carbohydrates through anaerobic fermentation, producing butyrate and propionate via the acetyl-CoA pathway. These short-chain fatty acids activate G-protein coupled receptors (GPR41 and GPR43) in colonocytes, strengthening tight junctions and reducing NF-κB inflammatory signaling. The butyrate serves as a primary energy source for colon cells while propionate travels to the liver to support glucose homeostasis.

Scientific Research

Eubacterium hallii research includes in vitro and animal studies, focusing on its role in gut health and metabolism. Human studies are limited but indicate potential benefits.

Clinical Summary

Research on Eubacterium hallii is primarily based on in vitro studies and small observational trials examining fecal microbiome composition. Studies have shown its depletion correlates with inflammatory bowel conditions and metabolic dysfunction in cohorts of 50-200 participants. Clinical trials specifically testing E. hallii supplementation are limited, with most evidence derived from broader microbiome intervention studies. The therapeutic potential is promising but requires larger randomized controlled trials to establish definitive clinical efficacy.

Nutritional Profile

- Produces butyrate and propionate, key short-chain fatty acids. - Contains enzymes that metabolize complex carbohydrates. - Rich in polysaccharides that promote gut health.

Preparation & Dosage

There is no standardized dosage for Eubacterium hallii supplements. Consult a healthcare provider before use.

Synergy & Pairings

Prebiotic Fiber,Omega-3 Fatty Acids,Polyphenols

Safety & Interactions

Eubacterium hallii appears generally safe as it naturally occurs in healthy human gut microbiomes. Potential side effects may include mild gastrointestinal discomfort, bloating, or gas during initial supplementation as the microbiome adjusts. No specific drug interactions have been documented, though immunosuppressive medications may theoretically reduce its colonization effectiveness. Safety data during pregnancy and breastfeeding is insufficient, so consultation with healthcare providers is recommended for these populations.